Table 4.
Dosage form | Total (n = 291), n (%) | Episodic headache (n = 172), n (%) | Chronic headache (n = 119), n (%) | OR [95% CI]a | P valueb |
---|---|---|---|---|---|
Oral | 274/291 (94.2) | 161/172 (93.6) | 113/119 (95.0) | 1.29 [0.46–3.59] | 0.6290 |
Intramuscolar | 59/291 (20.3) | 31/172 (18.0) | 28/119 (23.5) | 1.40 [0.79–2.49] | 0.2515 |
Subcutaneous | 31/291 (10.7) | 13/172 (7.6) | 18/119 (15.1) | 2.18 [1.02–4.67] | 0.0400 |
Rectal | 26/291 (8.9) | 12/172 (7.0) | 14/119 (11.8) | 1.78 [0.79–4.01] | 0.1599 |
Nasal spray | 6/291 (2.1) | 3/172 (1.7) | 3/119 (2.5) | 1.46 [0.29–7.37] | 0.6472 |
CI confidence interval, OR odds ratio
achronic vs episodic headache OR
bp value is derived from a Chi square test for homogeneity of odds